Alpha-1 anti-tripsin deficiency is an autosomal recessive genetic disease resulting in lung and liver damage
Presentation: 20-50yrs early onset COPD or liver cirrhosis
Presentation varies with smoking status and genetic subtype
Phenotypes: Z- severe disease, S mild disease, M normal
Alpha-1 anti-trypsin deficiency is an autosomal recessive genetic disease that results in a reduction of alpha-1 anti-trypsin which protects the body against neutrophil elastase
Neutrophil elastase causes alveoli destruction
Phenotypes: Z- severe disease, S mild disease, M normal
History
< 50yrs, mild smoking history
Progressive shortness of breath, cough, wheeze (COPD)
Abdominal distension
Examination
Stigmata of COPD- hyperinflated chest
Stigmata of liver cirrhosis- hepatomegaly, ascites, palmar erythema
Investigations
Raised Hb
Pulmonary function tests: obstructive picture
Genotyping
Diagnostic criteria: genotyping
Differentials: causes of COPD or liver cirrhosis
Classification: (severity) as per genotype-
SZ, ZZ - COPD & liver fibrosis < 30 years
SS, MZ only develop COPD is smoke
MS- largely normal
Acute
As per acute asthma: steroids, salbutamol, antibiotics if CXR consolidation
Long term
Alpha 1 anti-trypsin replacement, smoking cessation
Lung or liver transplants
Written in 2025